DC preparations for therapy

Cytotherapy

Volumn 6, Issue 2, 2004, Pages 99-104

  Rice, A M ^a   Jones, K L ^a   Hart, D N J ^a,b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b Mater Research   (Australia)

Author keywords

DC; Blood DC; Mo DC

Indexed keywords

B7 ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD86 ANTIGEN; CYTOKINE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LUCIFER YELLOW; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; PROSTAGLANDIN E2; T6 ANTIGEN; TETANUS TOXOID; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BLOOD CELL; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOCYTOSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LIFE CYCLE; MONOCYTE; NONHUMAN; PINOCYTOSIS; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 2642514164     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410005285     Document Type: Review

References (44)

1. Hart DNJ. Dendritic cells:unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-87.
2. Hart DNJ. Dendritic cells and their emerging clinical applications. Pathology 2001;33:478-91.
3. Clark GJ, Hart DNJ. Phenotypic characterization of dendritic cells. In: Lotze MT, Thomson AW editors. Dendritic cells: biology and clinical applications. USA: Academic Press, 1999:555-77.
4. Egner W, McKenzie JL, Smith SM et al. Identification of potent MLR stimulatory cells in human bone marrow. J Immunol 1993;150:3043.
5. + progenitors in human bone marrow. J Immunol 1992;149:2681-8.
6. + bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony stimulating factor and tumor necrosis factor-α. J Exp Med 1995;182:1111-20.
7. Caux C, Banchereau J. in vitro regulation of dendritic cell development and function. In: Whetton AD, Gordon J, editors. Blood cell chemistry: hematopoietic growth factors and their receptors. London: Plenum Press, 1996; Vol 7, 263-301.
8. + progenitors express CMRF-44 antigen early in the differentiation pathway. Immunol Cell Biol 2002;80:216-25.
9. Santiago-Schwarz F, Belilso E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leuk Biol 1992;52:274-81.
10. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
11. Santiago-Schwarz F, McCarthy M, Tucci J, Carsons SE. Neutralisation of tumor necrosis factor activity shortly after onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood 1998;92:745-55.
12. Santiago-Schwarz F, Divaris N, Kay C. Mechanisms of TNF/GM-CSF-induced dendritic cell development. Blood 1993;10:3019-28.
13. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony stimulating factor and TNFα J Immunol 1995;154:5851-61.
14. + blood progenitors for anti cancer therapy. Exp Hematol 1995;23:1463-71.
15. + cells. J Leuk Biol 1998;63:620-30.
16. Traycoff CM, Kosak ST, Grigsby S, Srour EF Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 1995;85:2059-68.
17. + cells. Br J Haematol 1998;101:756-65.
18. + human hematopoietic progenitor cells of the bone marrow differ from those of the peripheral blood: an immunocytochemical and morphometric study. Acta Haematol 1995;93:83-90.
19. + bone marrow and peripheral blood stem cells. Haematologica 2000;85:352-5.
20. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
21. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods 1996;96:137-51.
22. Zhou LJ, Tedder TE. Human blood dendritic cells selectively express CD83, a member of the immumoglobulin superfamily. J Immunol 1996;154:3821-35.
23. Peters JH, Giesler R, Thiele B, Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 1996;17:273-8.
24. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and down regulated by tumour necrosis factor α. J Exp Med 1994; 179:1109-18.
25. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
26. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
27. + leukocytes acquire the phenotype and function of antigen presenting dendritic cells when cultured in GM-CSF and IL-4. J Leuk Biol 1996;59:208-18.
28. Thurnher M, Zelle-Rieser C, Ramoner R et al. The disabled dendritic cell. FASEB J 2001;15:1054-61.
29. Xu H, Kramer M, Spengler HP, Peters JH. Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. Adv Exp Med Biol 1995;378:75-8.
30. Luft T, Luetjens P, Hochrein H et al. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002;14:367-80.
31. Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;21:52-8.
32. Rice A, Hart D. Technology evaluation: APC 80200, Dendreon. Curr Opin Mol Ther 2002;4:523-7.
33. Fearnley DB, McLellan AD, Mannering SI et al. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy. Blood 1997;89:3708-16.
34. Hock BD, Fearnley DB, Boyce A et al. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens 1999;53:320-34.
35. Lopez JA, Crosbie G, Kelly C et al. Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy. J Immunol Methods 2002;267:199-212.
36. Dzionek A, Fuchs A, Schmitz P et al. BDCA-2, BDCA-3 and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000;165:1646-55.
37. Luft T, Jefford M, Luetjens P et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002;100:1362-72.
38. Kato M, Neil TK, Fearnley DB et al. Expression of multilectin receptors and comparative FITC dextran uptake by human dendritic cells. Int Immunol 2000;12:1511-9.
39. + dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002;100:2858-66.
40. Ho CSK, Munster D, Pyke CM et al. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002;99:2897-904.
41. Reichardt VL, Okada CY, Liso A et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma-a feasibility study. Blood 1999;93:2411-9.
42. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony stimulating factor plus tumor necrosis factor-α: II functional analysis. Blood 1997;90:1458-70.
43. + T cells. J Immunol 1999;163:3597-604.
44. + hematopoietic progenitor cells. Immunobiology 1998;198:501-13.